Clinical response to sodium glucose co‐transporter 2 inhibitor ipragliflozin in a patient with metastatic renal cell carcinoma

by Keita Izumi, Yasumasa Iimura, Kiyoshi Hiruma, Tsuguhiro Touma, Tetsuro Tsukamoto
Published 2019-09-01